The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the ...

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

Three different drug combinations were equally effective in lowering blood pressure among people in a region where control ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy ...

The US Food and Drug Administration has approved revumenib (Revuforj — Syndax Pharmaceuticals) for relapsed or refractory ...

Those affected lose track in conversations and struggle to organize their thoughts. Fampridine is a drug that could help in such cases, as researchers led by Professor Andreas Papassotiropoulos and ...